Newsletter | July 1, 2025

Best of June: Top 5 Insights In Clinical Supply Chain & Logistics

Clinical Supply Leader

TOP 5 INSIGHTS IN CLINICAL SUPPLY CHAIN & LOGISTICS  

JUNE EDITION

#1 - Scaling Up Manufacturing? Here's Why You Need A CMC Specialist

CMC experts play a pivotal role in navigating the complexities of pharmaceutical scale-up. Their technical expertise ensures that the transition from development to commercial production is seamless, compliant, and optimized for efficiency. Here’s how they help manage key challenges:

#2 - Sample Sizes For Performance Testing Of Combination Products And Drug Packaging

When developing combination products or evaluating primary packaging for drug products one must evaluate the performance of the devices and the packaging to ensure that they are fit-for-purpose.

#3 - Bracing For The Impact Of The Federal Workforce Reduction

Federal workforce reductions pose significant challenges for the life sciences industry, particularly in sectors like biotechnology, medicine, and biology. This article provides a snapshot of what to expect with how the current reduction in force at the FDA impacts your life sciences company and products.

#4 - Formulation Is Key For Y-mAbs' Self-Assembling Antibody

Discover how Y-mAbs Therapeutics, Inc.'s novel self-assembly disassembly (SADA) construct uses self-assembling tetramers to deliver isotopes directly to cancer cells for a highly targeted, less toxic treatment

#5 - Multispecific Trial Supply Stability Hinges On CDMO Agility

Naya Therapeutic's CEO describes the dynamics of producing a complex therapeutic for clinical trials on another continent, and how choice of CDMO plays heavily into that strategy.